A33 Phase I Trial of in Situ Vaccination with Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined with Pembrolizumab for Advanced NSCLCB. Liu,A. Lisberg,R. Salehi-Rad,J.M. Lee,L.M. Tran,K. Krysan,R. Li,R.J. Lim,C. Dumitras,Z. Jing,F. Abtin,R.D. Suh,S.J. Genshaft,S. Oh,D.R. Aberle,L.E. Winter,S. Sharma,D. Elashoff,E.B. Garon,S.M. DubinettJournal of Thoracic Oncology（2020）引用 0|浏览57暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
